In four years with the Celtics, Rozier averaged 7.7 points, 3.6 rebounds and 2.3 assists per game on 38% from the field, 35.4% from 3 and 77.7% from the free-throw line. His most memorable stretch as a Celtic in the 2018 NBA Playoffs – the Scary Terry days that featured him as Boston’s starting guard – saw him averaging 16.5 points, 5.7 assists and 5.3 rebounds on 40.6% shooting from the field in 36.6 minutes.
This comes on the heels of news of Kyrie Irving’s departure and, to an extent, Kemba Walker’s arrival. Although things seemed bleak earlier this offseason after the report of both Irving and Al Horford leaving, the indication that Terry Rozier’s deal is a sign-and-trade could mean an opportunity to retain Al Horford while also gaining additional roster flexibility.
We’ll need more shoes to drop before we get the whole picture, but this being a sign-and-trade and not an outright offer sheet is very encouraging for a team that could sorely use Horford’s services next season. Stay tuned.
Time to pour cold water on Al Horford hopes and dreams, per Steve Bulpett of the Boston Herald:
Source close to Horford says that even after all the Celtics' cap gymnastics, he will not be winding up back in Boston.— Steve Bulpett (@SteveBHoop) June 30, 2019
That’s...unfortunate, though there are still benefits to executing a sign and trade, including more space to work with under the hard apron including the full MLE instead of the Room Exception. Stay locked to see how the Horford saga plays out as well as the exact terms of Rozier’s sign-and-trade deal.
Update to the update:
Sources: The Boston Celtics do not have a commitment from Al Horford to re-sign, but know they can't get one without the ability to offer him a deal at market value. Thus, they are arranging S&T deals to even be able to make the offer to Horford, while maintaining full MLE.— Keith Smith (@KeithSmithNBA) June 30, 2019
Hope, much like the 2018 Hospital Celtics, just won’t die.